Search

Filters
Clear All
  • 2
  • 16

Phase

  • 3
  • 2
  • 3
  • 1
  • 6
  • 3
  • 18

Found 18 site-public-contact trials

A listing of site-public-contact medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

S
Samantha Armstrong
18 years - 100 years
All genders
Phase 2
What is the purpose of this study?This phase II trial compares the effect of immunotherapy (pembrolizumab) plus chemotherapy (doxorubicin) to chemotherapy (doxorubicin) alone in treating patients with undifferentiated pleomorphic sarcoma (UPS) or a related poorly differentiated sarcoma that has spread from where it first started to other places in the …
P
Pravin Kaumaya
18 years - 100 years
All genders
Phase 1
What is the purpose of this study?Primary Objectives1. To determine the safety and toxicity profile of a chimeric HER2 B-cell peptide vaccine in patients with high-risk HER2 positive breast cancer after completion of standard curative therapy and adjuvant HER2-directed antibody therapy2. To determine immune responses induced by a chimeric HER2 …
R
Rita Assi
18 years - 100 years
All genders
Phase 3
What is the purpose of this study?The purpose of this study is to evaluate the efficacy of glofitamab monotherapy compared with an investigator's choice of either rituximab plus bendamustine (BR), or lenalidomide with rituximab (R-Len) in patients with relapsed or refractory (R/R) mantle cell lymphoma (MCL). Interested in participating? For more …
A
Anita Turk, MD
18 years - 100 years
All genders
Phase 2
What is the purpose of this study?The purpose of this study is to find out if adding two drugs called quemliclustat and zimberelimab to the usual chemotherapy drugs can increase the amount of time a person lives with biliary tract cancer without it getting worse. Researchers also want to study …
R
Rafat Abonour, MD
18 years - 100 years
All genders
Phase 3
What is the purpose of this study?The goal of this study (iMMagine-3) is to compare the study drug, anitocabtagene autoleucel to standard of care therapy (SOCT) in participants with relapsed/refractory multiple myeloma who have received 1 to 3 prior lines of therapy, including an anti-CD38 monoclonal antibody and an immunomodulatory …
K
Kathy Miller, MD
18 years - 100 years
All genders
Phase 1
What is the purpose of this study?Primary 1. To assess the safety and tolerability of the combination of CLBR001 + ABBV-461 in subjects with locally advanced or metastatic breast cancer. 2. To identify an Optimal Biologic Dose (OBD) and/or a Maximum Tolerated Dose (MTD) of CLBR001 and ABBV-461. Secondary 1. …
M
Misty D. Shields, MD, PhD
18 years - 100 years
All genders
Phase 1/2
What is the purpose of this study?BDTX-1535-101 is an open-label, Phase 1 dose escalation and Phase 2 multiple cohort study designed to evaluate the safety, pharmacokinetics (PK), optimal dosage, central nervous system (CNS) activity, and antitumor activity of BDTX-1535. The study population comprises adults with either advanced/metastatic non-small cell lung …
G
Greg Durm, MD
18 years - 100 years
All genders
Phase 1
What is the purpose of this study?This is a Phase 1a/1b, open-label, dose escalation and expansion study to evaluate the safety and anti-tumor activity of DAY301, a PTK7-directed antibody-drug conjugate in patients with advanced or metastatic solid tumors.  Interested in participating? For more information about this research study or other cancer-related …
11 - 18 of 18